# Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer

> **NCT00540280** · PHASE3 · SUSPENDED · sponsor: **King Faisal Specialist Hospital & Research Center** · enrollment: 10 (estimated)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **RADIATION:** Surgery alone or surgery plus preoperative Gemcitabine-Cisplatin

## Key facts

- **NCT ID:** NCT00540280
- **Lead sponsor:** King Faisal Specialist Hospital & Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2003-10
- **Primary completion:** 2003-10
- **Final completion:** 2013-10
- **Target enrollment:** 10 (ESTIMATED)
- **Why stopped:** Follow up only
- **Last updated:** 2011-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00540280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00540280, "Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00540280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*